Journal list menu
Export Citations
Download PDFs
Cover Image
Issue Information
Hepatology Highlights
Comments from the Editors
Free Access
free
Social media: Why AASLD and its members must lead the conversation
- Pages: 4-6
- First Published: 14 April 2018
Editorials
Free Access
free
Hepatocellular carcinoma screening is associated with survival benefit in silico but needs confirmation in an in vivo analysis
- Pages: 7-9
- First Published: 09 January 2018
Free Access
free
Identification of theranostic biomarkers to improve the stratification of patients with pediatric liver cancer: Opportunities and challenges
- Pages: 10-12
- First Published: 12 January 2018
Free Access
free
Hepatocellular carcinoma: Liver biopsy in the balance
- Pages: 13-15
- First Published: 05 February 2018
Free Access
free
Quality of life and primary sclerosing cholangitis: The business of defining what counts
- Pages: 16-18
- First Published: 09 January 2018
Free Access
free
Primary biliary cholangitis, DNA, and beyond: The Relative contribution of genes
- Pages: 19-21
- First Published: 13 January 2018
Original Articles
VIRAL HEPATITIS
Free Access
free
Serologic responses and effectiveness of hepatitis A vaccination among human immunodeficiency virus–positive individuals during the outbreak of acute hepatitis A
- Pages: 22-31
- First Published: 12 January 2018
Open Access
oa
All-oral direct-acting antiviral therapy against hepatitis C virus (HCV) in human immunodeficiency virus/HCV–coinfected subjects in real-world practice: Madrid coinfection registry findings
- Pages: 32-47
- First Published: 29 January 2018
STEATOHEPATITIS/METABOLIC LIVER DISEASE
Free Access
free
Disruption of adenosine 2A receptor exacerbates NAFLD through increasing inflammatory responses and SREBP1c activity
- Pages: 48-61
- First Published: 09 January 2018
Free Access
free
Cyclophilin D deficiency attenuates mitochondrial perturbation and ameliorates hepatic steatosis
- Pages: 62-77
- First Published: 21 January 2018
HEPATOBILIARY MALIGNANCIES
Free Access
free
Impact of surveillance for hepatocellular carcinoma on survival in patients with compensated cirrhosis
- Pages: 78-88
- First Published: 12 October 2017
Free Access
free
New insights into diagnosis and therapeutic options for proliferative hepatoblastoma
- Pages: 89-102
- First Published: 20 November 2017
Free Access
free
Macrotrabecular-massive hepatocellular carcinoma: A distinctive histological subtype with clinical relevance
- Pages: 103-112
- First Published: 27 December 2017
Free Access
free
cHCC-CCA: Consensus terminology for primary liver carcinomas with both hepatocytic and cholangiocytic differentation
- Pages: 113-126
- First Published: 23 January 2018
Free Access
free
Single-cell analysis reveals cancer stem cell heterogeneity in hepatocellular carcinoma
- Pages: 127-140
- First Published: 09 January 2018
Open Access
oa
Hepatocellular carcinoma–related cyclin D1 is selectively regulated by autophagy degradation system
- Pages: 141-154
- First Published: 12 January 2018
AUTOIMMUNE, CHOLESTATIC AND BILIARY DISEASE
Free Access
free
Development and validation of a primary sclerosing cholangitis–specific patient-reported outcomes instrument: The PSC PRO
- Pages: 155-165
- First Published: 20 November 2017
Free Access
free
Using the Icelandic genealogical database to define the familial risk of primary biliary cholangitis
- Pages: 166-171
- First Published: 21 November 2017
Free Access
free
MAIT cells are chronically activated in patients with autoimmune liver disease and promote profibrogenic hepatic stellate cell activation
- Pages: 172-186
- First Published: 12 January 2018
Open Access
oa
Bile acids stimulate cholangiocyte fluid secretion by activation of transmembrane member 16A Cl− channels
- Pages: 187-199
- First Published: 23 January 2018
Free Access
free
Carcinoembryonic antigen-related cell adhesion molecule 1 controls IL-2-dependent regulatory T-cell induction in immune-mediated hepatitis in mice
- Pages: 200-214
- First Published: 29 January 2018
LIVER FAILURE/CIRRHOSIS/PORTAL HYPERTENSION
Free Access
free
Cardiovascular predictors of death in patients with cirrhosis
- Pages: 215-223
- First Published: 13 September 2017
Free Access
free
Fractional excretion of urea: A simple tool for the differential diagnosis of acute kidney injury in cirrhosis
- Pages: 224-233
- First Published: 08 January 2018
Free Access
free
Diet affects gut microbiota and modulates hospitalization risk differentially in an international cirrhosis cohort
- Pages: 234-247
- First Published: 19 January 2018
Free Access
free
Khat chewing increases the risk for developing chronic liver disease: A hospital-based case–control study
- Pages: 248-257
- First Published: 25 January 2018
LIVER INJURY/REGENERATION
Free Access
free
Recombinant relaxin protects liver transplants from ischemia damage by hepatocyte glucocorticoid receptor: From bench-to-bedside
- Pages: 258-273
- First Published: 19 January 2018
Liver Biology and Pathobiology
Free Access
free
Patterning of the hepato-pancreatobiliary boundary by BMP reveals heterogeneity within the murine liver bud
- Pages: 274-288
- First Published: 05 January 2018
Open Access
oa
Hepatic PPARα function is controlled by polyubiquitination and proteasome-mediated degradation through the coordinated actions of PAQR3 and HUWE1
- Pages: 289-303
- First Published: 13 January 2018
Free Access
free
Farnesoid X receptor signaling activates the hepatic X-box binding protein 1 pathway in vitro and in mice
- Pages: 304-316
- First Published: 29 January 2018
Open Access
oa
Basolateral CD147 induces hepatocyte polarity loss by E-cadherin ubiquitination and degradation in hepatocellular carcinoma progress
- Pages: 317-332
- First Published: 21 January 2018
Free Access
free
Hepatic stellate cell–derived platelet-derived growth factor receptor-alpha-enriched extracellular vesicles promote liver fibrosis in mice through SHP2
- Pages: 333-348
- First Published: 23 January 2018
Reviews
Free Access
free
Diagnostic modalities for nonalcoholic fatty liver disease, nonalcoholic steatohepatitis, and associated fibrosis
- Pages: 349-360
- First Published: 09 December 2017
Free Access
free
Current and future therapeutic regimens for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
- Pages: 361-371
- First Published: 09 December 2017
Hepatology Elsewhere
Free Access
free
Thwart your destiny; effect of nonacoholic fatty liver disease genes on steatosis, liver injury and cirrhosis varies by body mass index
- Pages: 372-374
- First Published: 18 December 2017
Free Access
free
Of mice, rats, and men: Small animal model of hepatitis C virus infection
- Pages: 374-376
- First Published: 27 December 2017
Free Access
free
Proton pump inhibitors, Enterococcus, and the liver, oh my!
- Pages: 376-379
- First Published: 30 January 2018
Clinical Observations in Hepatology
Free Access
free
Nonstructural protein 5A/P32 deletion after failure of ledipasvir/sofosbuvir in hepatitis C virus genotype 1b infection
- Pages: 380-383
- First Published: 09 February 2018
Free Access
free
Favorable response to mammalian target of rapamycin inhibition in a young patient with unresectable fibrolamellar carcinoma of the liver
- Pages: 384-386
- First Published: 23 February 2018
Correspondence
Free Access
free
Growth factor therapy for decompensated cirrhosis: Much ado about nothing?
- Pages: 387-388
- First Published: 03 March 2018
Free Access
free
Nonalcoholic fatty liver disease: Is it time for combination treatment and a diabetes-like approach?
- Page: 389
- First Published: 30 March 2018